|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iacobuzio-Donahue CA: Genetic evolution of
pancreatic cancer: Lessons learnt from the pancreatic cancer genome
sequencing project. GUT. 61:1085–1094. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yachida S, Jones S, Bozic I, Antal T,
Leary R, Fu B, Kamiyama M, Hruban RH, Eshleman JR, Nowak MA, et al:
Distant metastasis occurs late during the genetic evolution of
pancreatic cancer. Nature. 467:1114–1117. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
György B, Szabó TG, Pásztói M, Pál Z,
Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al:
Membrane vesicles, current state-of-the-art: Emerging role of
extracellular vesicles. Cell Mol Life Sci. 68:2667–2688. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simons M and Raposo G: Exosomes-vesicular
carriers for intercellular communication. Curr Opin Cell Biol.
21:575–581. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cocucci E and Meldolesi J: Ectosomes and
exosomes: Shedding the confusion between extracellular vesicles.
Trends Cell Biol. 25:364–372. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cocucci E and Meldolesi J: Ectosomes. Curr
Biol. 21:R940–R941. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Costa-Silva B, Aiello NM, Ocean AJ, Singh
S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, et
al: Pancreatic cancer exosomes initiate pre-metastatic niche
formation in the liver. Nat Cell Biol. 17:816–826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Christianson HC, Svensson KJ, van
Kuppevelt TH, Li JP and Belting M: Cancer cell exosomes depend on
cell-surface heparan sulfate proteoglycans for their
internalization and functional activity. Proc Natl Acad Sci USA.
110:17380–17385. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Miyanishi M, Tada K, Koike M, Uchiyama Y,
Kitamura T and Nagata S: Identification of Tim4 as a
phosphatidylserine receptor. Nature. 450:435–439. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoshino A, Costa-Silva B, Shen TL,
Rodrigues G, Hashimoto A, Mark Tesic M, Molina H, Kohsaka S, Di
Giannatale A, Ceder S, et al: Tumour exosome integrins determine
organotropic metastasis. Nature. 527:329–335. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nazarenko I, Rana S, Baumann A, McAlear J,
Hellwig A, Trendelenburg M, Lochnit G, Preissner KT and Zöller M:
Cell surface tetraspanin Tspan8 contributes to molecular pathways
of exosome-induced endothelial cell activation. Cancer Res.
70:1668–1678. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zöller M: Exosomes in cancer disease.
Methods Mol Biol. 1381:111–149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J,
Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable
in exosomes: A promising biomarker for cancer diagnosis. Cell Res.
25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ge Q, Zhou Y, Lu J, Bai Y, Xie X and Lu Z:
miRNA in plasma exosome is stable under different storage
conditions. Molecules. 19:1568–1575. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Subra C, Grand D, Laulagnier K, Stella A,
Lambeau G, Paillasse M, De Medina P, Monsarrat B, Perret B,
Silvente-Poirot S, et al: Exosomes account for vesicle-mediated
transcellular transport of activatable phospholipases and
prostaglandins. J Lipid Res. 51:2105–2120. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Beloribi S, Ristorcelli E, Breuzard G,
Silvy F, Bertrand-Michel J, Beraud E, Verine A and Lombardo D:
Exosomal lipids impact notch signaling and induce death of human
pancreatic tumoral SOJ-6 cells. PLoS One. 7:e474802012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beloribi-Djefaflia S, Siret C and Lombardo
D: Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells
resistance through the CXCR4-SDF-1α signaling axis. Oncoscience.
2:15–30. 2014.PubMed/NCBI
|
|
19
|
Llorente A, Skotland T, Sylvänne T,
Kauhanen D, Róg T, Orłowski A, Vattulainen I, Ekroos K and Sandvig
K: Molecular lipidomics of exosomes released by PC-3 prostate
cancer cells. Biochim Biophys Acta. 1831:1302–1309. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Minciacchi VR, You S, Spinelli C, Morley
S, Zandian M, Aspuria PJ, Cavallini L, Ciardiello C, Sobreiro Reis
M, Morello M, et al: Large oncosomes contain distinct protein cargo
and represent a separate functional class of tumor-derived
extracellular vesicles. Oncotarget. 6:11327–11341. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Keerthikumar S, Gangoda L, Liem M, Fonseka
P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS and
Mathivanan S: Proteogenomic analysis reveals exosomes are more
oncogenic than ectosomes. Oncotarget. 6:15375–15396. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lötvall J, Hill AF, Hochberg F, Buzás EI,
Di Vizio D, Gardiner C, Gho YS, Kurochkin IV, Mathivanan S,
Quesenberry P, et al: Minimal experimental requirements for
definition of extracellular vesicles and their functions: A
position statement from the International Society for Extracellular
Vesicles. J Extracell Vesicles. 3:269132014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zöller M: Tetraspanins: Push and pull in
suppressing and promoting metastasis. Nat Rev Cancer. 9:40–55.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pols MS and Klumperman J: Trafficking and
function of the tetraspanin CD63. Exp Cell Res. 315:1584–1592.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yue S, Mu W, Erb U and Zöller M: The
tetraspanins CD151 and Tspan8 are essential exosome components for
the crosstalk between cancer initiating cells and their
surrounding. Oncotarget. 6:2366–2384. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Henderson MC and Azorsa DO: The genomic
and proteomic content of cancer cell-derived exosomes. Front Oncol.
2:382012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Raimondo F, Morosi L, Chinello C, Magni F
and Pitto M: Advances in membranous vesicle and exosome proteomics
improving biological understanding and biomarker discovery.
Proteomics. 11:709–720. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Runz S, Keller S, Rupp C, Stoeck A, Issa
Y, Koensgen D, Mustea A, Sehouli J, Kristiansen G and Altevogt P:
Malignant ascites-derived exosomes of ovarian carcinoma patients
contain CD24 and EpCAM. Gynecol Oncol. 107:563–571. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Al-Nedawi K, Meehan B, Micallef J, Lhotak
V, May L, Guha A and Rak J: Intercellular transfer of the oncogenic
receptor EGFRvIII by microvesicles derived from tumour cells. Nat
Cell Biol. 10:619–624. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Corcoran C, Rani S, O'Brien K, O'Neill A,
Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J and
O'Driscoll L: Docetaxel-resistance in prostate cancer: Evaluating
associated phenotypic changes and potential for resistance transfer
via exosomes. PLoS One. 7:e509992012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Beckler Demory M, Higginbotham JN,
Franklin JL, Ham AJ, Halvey PJ, Imasuen IE, Whitwell C, Li M,
Liebler DC and Coffey RJ: Proteomic analysis of exosomes from
mutant KRAS colon cancer cells identifies intercellular transfer of
mutant KRAS. Mol Cell Proteomics. 12:343–355. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji H, Greening DW, Barnes TW, Lim JW,
Tauro BJ, Rai A, Xu R, Adda C, Mathivanan S, Zhao W, et al:
Proteome profiling of exosomes derived from human primary and
metastatic colorectal cancer cells reveal differential expression
of key metastatic factors and signal transduction components.
Proteomics. 13:1672–1686. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park JA, Sharif AS, Tschumperlin DJ, Lau
L, Limbrey R, Howarth P and Drazen JM: Tissue factor-bearing
exosome secretion from human mechanically stimulated bronchial
epithelial cells in vitro and in vivo. J Allergy Clin Immunol.
130:1375–1383. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Adamczyk KA, Klein-Scory S, Tehrani MM,
Warnken U, Schmiegel W, Schnölzer M and Schwarte-Waldhoff I:
Characterization of soluble and exosomal forms of the EGFR released
from pancreatic cancer cells. Life Sci. 89:304–312. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Salido-Guadarrama I, Romero-Cordoba S,
Peralta-Zaragoza O, Hidalgo-Miranda A and Rodríguez-Dorantes M:
MicroRNAs transported by exosomes in body fluids as mediators of
intercellular communication in cancer. Onco Targets Ther.
7:1327–1338. 2014.PubMed/NCBI
|
|
36
|
Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy
SL, Breakefield XO and Skog J: Tumour microvesicles contain
retrotransposon elements and amplified oncogene sequences. Nat
Commun. 2:1802011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gibbings DJ, Ciaudo C, Erhardt M and
Voinnet O: Multivesicular bodies associate with components of miRNA
effector complexes and modulate miRNA activity. Nat Cell Biol.
11:1143–1149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Medina PP, Nolde M and Slack FJ: OncomiR
addiction in an in vivo model of microRNA-21-induced pre-B-cell
lymphoma. Nature. 467:86–90. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Costinean S, Zanesi N, Pekarsky Y, Tili E,
Volinia S, Heerema N and Croce CM: Pre-B cell proliferation and
lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155
transgenic mice. Proc Natl Acad Sci USA. 103:7024–7029. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mikamori M, Yamada D, Eguchi H, Hasegawa
S, Kishimoto T, Tomimaru Y, Asaoka T, Noda T, Wada H, Kawamoto K,
et al: MicroRNA-155 controls exosome synthesis and promotes
gemcitabine resistance in pancreatic ductal adenocarcinoma. Sci
Rep. 7:423392017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Manier S, Liu CJ, Avet-Loiseau H, Park J,
Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, et
al: Prognostic role of circulating exosomal miRNAs in multiple
myeloma. Blood. 129:2429–2436. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cortez MA, Bueso-Ramos C, Ferdin J,
Lopez-Berestein G, Sood AK and Calin GA: MicroRNAs in body
fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol.
8:467–477. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Boeri M, Verri C, Conte D, Roz L, Modena
P, Facchinetti F, Calabrò E, Croce CM, Pastorino U and Sozzi G:
MicroRNA signatures in tissues and plasma predict development and
prognosis of computed tomography detected lung cancer. Proc Natl
Acad Sci USA. 108:3713–3718. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Memczak S, Jens M, Elefsinioti A, Torti F,
Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer
M, et al: Circular RNAs are a large class of animal RNAs with
regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li Q, Shao Y, Zhang X, Zheng T, Miao M,
Qin L, Wang B, Ye G, Xiao B and Guo J: Plasma long noncoding RNA
protected by exosomes as a potential stable biomarker for gastric
cancer. Tumour Biol. 36:2007–2012. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Takahashi K, Yan IK, Kogure T, Haga H and
Patel T: Extracellular vesicle-mediated transfer of long non-coding
RNA ROR modulates chemosensitivity in human hepatocellular cancer.
FEBS Open Bio. 4:458–467. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mohme M, Riethdorf S and Pantel K:
Circulating and disseminated tumour cells-mechanisms of immune
surveillance and escape. Nat Rev Clin Oncol. 14:155–167. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yu S, Cao H, Shen B and Feng J:
Tumor-derived exosomes in cancer progression and treatment failure.
Oncotarget. 6:37151–37168. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Melo SA, Sugimoto H, O'Connell JT, Kato N,
Villanueva A, Vidal A, Qiu L, Vitkin E, Perelman LT, Melo CA, et
al: Cancer exosomes perform cell-independent microRNA biogenesis
and promote tumorigenesis. Cancer Cell. 26:707–721. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Abd Elmageed ZY, Yang Y, Thomas R, Ranjan
M, Mondal D, Moroz K, Fang Z, Rezk BM, Moparty K, Sikka SC, et al:
Neoplastic reprogramming of patient-derived adipose stem cells by
prostate cancer cell-associated exosomes. Stem Cells. 32:983–997.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Falasca M, Kim M and Casari I: Pancreatic
cancer: Current research and future directions. Biochim Biophys
Acta. 1865:123–132. 2016.PubMed/NCBI
|
|
56
|
Zhang X, Yuan X, Shi H, Wu L, Qian H and
Xu W: Exosomes in cancer: Small particle, big player. J Hematol
Oncol. 8:832015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hong BS, Cho JH, Kim H, Choi EJ, Rho S,
Kim J, Kim JH, Choi DS, Kim YK, Hwang D and Gho YS: Colorectal
cancer cell-derived microvesicles are enriched in cell
cycle-related mRNAs that promote proliferation of endothelial
cells. BMC Genomics. 10:5562009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Le MT, Hamar P, Guo C, Basar E,
Perdigão-Henriques R, Balaj L and Lieberman J: miR-200-containing
extracellular vesicles promote breast cancer cell metastasis. J
Clin Invest. 124:5109–5128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Qu JL, Qu XJ, Zhao MF, Teng YE, Zhang Y,
Hou KZ, Jiang YH, Yang XH and Liu YP: Gastric cancer exosomes
promote tumour cell proliferation through PI3K/Akt and MAPK/ERK
activation. Dig Liver Dis. 41:875–880. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Takikawa T, Masamune A, Yoshida N, Hamada
S, Kogure T and Shimosegawa T: Exosomes derived from pancreatic
stellate cells: MicroRNA signature and effects on pancreatic cancer
cells. Pancreas. 46:19–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
An M, Lohse I, Tan Z, Zhu J, Wu J,
Kurapati H, Morgan MA, Lawrence TS, Cuneo KC and Lubman DM:
Quantitative proteomic analysis of serum exosomes from patients
with locally advanced pancreatic cancer undergoing
chemoradiotherapy. J Proteome Res. 16:1763–1772. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liu Y, Gu Y and Cao X: The exosomes in
tumor immunity. Oncoimmunology. 4:e10274722015. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Zhou M, Chen J, Zhou L, Chen W, Ding G and
Cao L: Pancreatic cancer derived exosomes regulate the expression
of TLR4 in dendritic cells via miR-203. Cell Immunol. 292:65–69.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Ding G, Zhou L, Qian Y, Fu M, Chen J, Chen
J, Xiang J, Wu Z, Jiang G and Cao L: Pancreatic cancer-derived
exosomes transfer miRNAs to dendritic cells and inhibit RFXAP
expression via miR-212-3p. Oncotarget. 6:29877–29888. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wynn TA, Chawla A and Pollard JW:
Macrophage biology in development, homeostasis and disease. Nature.
496:445–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Su MJ, Aldawsari H and Amiji M: Pancreatic
cancer cell exosome-mediated macrophage reprogramming and the role
of MicroRNAs 155 and 125b2 transfection using nanoparticle delivery
systems. Sci Rep. 6:301102016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Katsiougiannis S, Chia D, Kim Y, Singh RP
and Wong DT: Saliva exosomes from pancreatic tumor-bearing mice
modulate NK cell phenotype and antitumor cytotoxicity. FASEB J.
31:998–1010. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sagar G, Sah RP, Javeed N, Dutta SK, Smyrk
TC, Lau JS, Giorgadze N, Tchkonia T, Kirkland JL, Chari ST and
Mukhopadhyay D: Pathogenesis of pancreatic cancer exosome-induced
lipolysis in adipose tissue. Gut. 65:1165–1174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Javeed N, Sagar G, Dutta SK, Smyrk TC, Lau
JS, Bhattacharya S, Truty M, Petersen GM, Kaufman RJ, Chari ST and
Mukhopadhyay D: Pancreatic cancer-derived exosomes cause
paraneoplastic β-cell dysfunction. Clin Cancer Res. 21:1722–1733.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Patel GK, Patton MC, Singh S, Khushman M
and Singh AP: Pancreatic cancer exosomes: Shedding off for a
meaningful journey. Pancreat Disord Ther. 6:e1482016. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Oettle H, Post S, Neuhaus P, Gellert K,
Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C,
et al: Adjuvant chemotherapy with gemcitabine vs observation in
patients undergoing curative-intent resection of pancreatic cancer:
A randomized controlled trial. JAMA. 297:267–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Wei Y, Lai X, Yu S, Chen S, Ma Y, Zhang Y,
Li H, Zhu X, Yao L and Zhang J: Exosomal miR-221/222 enhances
tamoxifen resistance in recipient ER-positive breast cancer cells.
Breast Cancer Res Treat. 147:423–431. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Richards KE, Zeleniak AE, Fishel ML, Wu J,
Littlepage LE and Hill R: Cancer-associated fibroblast exosomes
regulate survival and proliferation of pancreatic cancer cells.
Oncogene. 36:1770–1778. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Valenzuela Asuncion MM, Castro I, Gonda A,
Osterman Diaz CJ, Jutzy JM, Aspe JR, Khan S, Neidigh JW and Wall
NR: Cell death in response to antimetabolites directed at
ribonucleotide reductase and thymidylate synthase. Onco Targets
Ther. 8:495–507. 2015.PubMed/NCBI
|
|
76
|
Valenzuela MM, Bennit Ferguson HR, Gonda
A, Osterman Diaz CJ, Hibma A, Khan S and Wall NR: Exosomes secreted
from human cancer cell lines contain Inhibitors of Apoptosis (IAP).
Cancer Microenviron. 8:65–73. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Que R, Ding G, Chen J and Cao L: Analysis
of serum exosomal microRNAs and clinicopathologic features of
patients with pancreatic adenocarcinoma. World J Surg Oncol.
11:2192013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lu L and Risch HA: Exosomes: Potential for
early detection in pancreatic cancer. Future Oncol. 12:1081–1090.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Joshi GK, Deitz-McElyea S, Liyanage T,
Lawrence K, Mali S, Sardar R and Korc M: Label-Free
nanoplasmonic-based short noncoding RNA sensing at attomolar
concentrations allows for quantitative and highly specific assay of
MicroRNA-10b in biological fluids and circulating exosomes. ACS
Nano. 9:11075–11089. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Madhavan B, Yue S, Galli U, Rana S, Gross
W, Müller M, Giese NA, Kalthoff H, Becker T, Büchler MW and Zöller
M: Combined evaluation of a panel of protein and miRNA
serum-exosome biomarkers for pancreatic cancer diagnosis increases
sensitivity and specificity. Int J Cancer. 136:2616–2627. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari
N, et al: Glypican-1 identifies cancer exosomes and detects early
pancreatic cancer. Nature. 523:177–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Ben Q, Xu M, Ning X, Liu J, Hong S, Huang
W, Zhang H and Li Z: Diabetes mellitus and risk of pancreatic
cancer: A meta-analysis of cohort studies. Eur J Cancer.
47:1928–1937. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Huxley R, Ansary-Moghaddam A, de González
Berrington A, Barzi F and Woodward M: Type-II diabetes and
pancreatic cancer: A meta-analysis of 36 studies. Br J Cancer.
92:2076–2083. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Liu Y and Cao X: Organotropic metastasis:
Role of tumor exosomes. Cell Res. 26:149–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
